A. Brooke

Distinct Modulatory Effects of Satiety and Sibutramine on Brain Responses to Food Images in Humans: A Double Dissociation across Hypothalamus, Amygdala, and Ventral Striatum

Sam R. Miller, E. Bullmore, P. Fletcher, 2010, The Journal of Neuroscience.

Prediction of Weight Loss and Regain Following Dietary, Lifestyle, and Pharmacologic Intervention

Sam R. Miller, P. Murgatroyd, A. Vidal-Puig, 2012, Clinical pharmacology and therapeutics.

The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans

B. Chizh, A. Napolitano, R. Lai, 2007, Pain.

Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects

E. Bullmore, L. Cheke, P. Fletcher, 2012, Molecular Psychiatry.

Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist

Pradeep J Nathan, Edward T Bullmore, E. Bullmore, 2012, Journal of clinical pharmacology.

Multiple‐Dose Safety, Pharmacokinetics, and Pharmacodynamics of the μ‐Opioid Receptor Inverse Agonist GSK1521498

E. Bullmore, P. Nathan, B. O’Neill, 2012, Journal of clinical pharmacology.

Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects

E. Bullmore, L. Cheke, P. Fletcher, 2014, Molecular Psychiatry.